The mission of this revolutionary analytics platform is to reveal precise predictive clinical analytics, which will grant operational, clinical, and financial benefits to healthcare staff and management. In particular, this analytical data will help patients whose lives are on the brink and in immediate danger.
“As a key industry initiator, catalyst, and testing center for Israeli medical technology, Sheba is pleased to collaborate with CLEW,” says Mr. Eyal Zimlichman, MD, MSc (MHCM), Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center. “We are enthusiastic about harnessing their sophisticated technologies and predictive analytics for the sake of improving patients’ health.”
CLEW, founded by CEO Gal Salomon, uses artificial intelligence and data science to develop physiological predictive models on the individual patient level. These models are being used in all care settings in order to guide healthcare providers with predictions about the state of the patient. CLEW helps medical teams to make better-informed clinical decisions, streamline patient care, improve safety and outcomes, deal more efficiently with increased regulation and penalties, and lower the cost of care.
In response to CLEW’s new and promising partnership with Sheba, Gal Salomon says, “We are excited to partner with the prestigious Sheba Medical Center to further develop our real-time predictive analytics platform in a clinical setting.” This collaborative program marks the first time CLEW’s technology will be implemented in a global setting, thereby bringing CLEW much closer to their goal of enabling early clinical intervention in medical facilities around the world. The sooner clinicians can intervene in patient care, the better they can prevent unnecessary complications, reduce mortality, and ultimately save more lives.
